SI

Venom’s BlackBook Zero 14 honoured with HPL best business laptop award

Retrieved on: 
Thursday, May 9, 2024
PC Gamer, HPL, Magnesium alloy, Glass, News, BlackBook, SMB, SOHO, Computer, TechRadar, WH, High, Intel Core, Facial recognition, APC, PC, DDR5, AC, SSD, Government, Windows 10, USB, PC World, Data-rate units, Video game

MELBOURNE, Australia, May 09, 2024 (GLOBE NEWSWIRE) -- Venom, manufacturer of performance orientated laptop computers has been recognised by HPL (High performance Laptops) for the Best Business laptop award.

Key Points: 
  • MELBOURNE, Australia, May 09, 2024 (GLOBE NEWSWIRE) -- Venom, manufacturer of performance orientated laptop computers has been recognised by HPL (High performance Laptops) for the Best Business laptop award.
  • The emphasis of the best business laptop award is on weight, battery life, screen quality and size, ports and connectivity, web conferencing, build quality, security and service level agreements.
  • Venom’s BlackBook Zero 14 Phantom G9 scored the highest in these categories overall thus winning the category award for best business laptop.
  • Factors contributing to the award are the BlackBook Zero 14 Phantom G9’s lightweight portable design and high-speed performance.

SI-BONE Expands Portfolio with the Launch of New Offering for the iFuse Bedrock Granite Implant System and Completes Inaugural Surgical Procedures

Retrieved on: 
Tuesday, May 7, 2024
FDA, University, Henry Ford Health, Sacrum, Food, DSM-IV codes, Surgeon, S1, Columbia University, Workflow, Motion, Anatomy, Joint, Spine, Patient, Silicon, Medicare, Deformity, Dentistry

When placed across the SI joint, the Granite implant provides sacroiliac fusion and spinopelvic fixation as a foundational element for multi-segment spinal fusion.

Key Points: 
  • When placed across the SI joint, the Granite implant provides sacroiliac fusion and spinopelvic fixation as a foundational element for multi-segment spinal fusion.
  • The iFuse Bedrock Granite Implant System was awarded a Breakthrough Device Designation by the Food & Drug Administration and a New Technology Add-on Payment by the Centers for Medicare and Medicaid Services.
  • More importantly, even with complex reconstructions, as in my experience for my first Granite 9.5 case, the implant did not change my surgical workflow.
  • The S1 Granite 9.5 implants were a welcome addition to the 10.5 mm Granite implants I use for sacroalar-iliac fixation in my constructs.

Rapaport Press Release: Prices of Higher-Clarity Diamonds Continue to Fall

Retrieved on: 
Tuesday, May 7, 2024
Jewelry, Natural Resources, Luxury, Retail, Mining, Minerals, Diamond, Anglo American, Gold, Pressure, Sis, VS, De Beers

Prices of VS-plus goods fell, while SIs improved, continuing a trend that has been present since the start of the year.

Key Points: 
  • Prices of VS-plus goods fell, while SIs improved, continuing a trend that has been present since the start of the year.
  • BHP’s $38.9 billion bid for Anglo American ­raised questions about the future of De Beers.
  • Anglo is also reportedly trying to sell De Beers in a separate process that could lead to a restructuring of the diamond market.
  • Prices for round, 1-carat, D to H, SI diamonds increased 1% in April.

Nevro Reports First-Quarter 2024 Financial Results

Retrieved on: 
Tuesday, May 7, 2024
FDA, Internet access, SCS, International, Investment, Risk, Depreciation, Research, Webcast, HFX, Journal, Tax, Senior, PDN, Patient, Acquisition, Physician, Event, Christoforou, Hertz, RCT, Chronic pain, GAAP, Growth

REDWOOD CITY, Calif., May 7, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today reported its first quarter 2024 financial results. The company also announced additional restructuring steps to advance its strategy and accelerate profitability, raised its adjusted EBITDA guidance and reaffirmed its revenue guidance for the full-year 2024, and announced that Christofer Christoforou has been promoted to the newly created Chief Operating Officer (COO) role.

Key Points: 
  • REDWOOD CITY, Calif., May 7, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today reported its first quarter 2024 financial results.
  • Reported a first quarter 2024 net loss from operations of $35.8 million; first quarter 2024 adjusted EBITDA was a loss of $9.6 million.
  • As previously announced, Nevro will host a conference call today to discuss its financial results.
  • The company encourages investors and potential investors to consult the Nevro website regularly for important information about Nevro.

Venom's BlackBook Zero 14 Honored with HPL Best Business Laptop Award

Retrieved on: 
Tuesday, May 7, 2024
PC Gamer, HPL, ABC, Magnesium alloy, Glass, News, BlackBook, SMB, SOHO, Computer, TechRadar, WH, High, Intel Core, Facial recognition, APC, PC, DDR5, AC, SSD, Government, Windows 10, USB, PC World, Data-rate units

MELBOURNE, Australia, May 7, 2024 /PRNewswire/ -- Venom, manufacturer of performance orientated laptop computers has been recognised by HPL (High performance Laptops) for the Best Business laptop award.

Key Points: 
  • MELBOURNE, Australia, May 7, 2024 /PRNewswire/ -- Venom, manufacturer of performance orientated laptop computers has been recognised by HPL (High performance Laptops) for the Best Business laptop award.
  • The emphasis of the best business laptop award is on weight, battery life, screen quality and size, ports and connectivity, web conferencing, build quality, security and service level agreements.
  • Venom's BlackBook Zero 14 Phantom G9 scored the highest in these categories overall thus winning the category award for best business laptop.
  • Factors contributing to the award are the BlackBook Zero 14 Phantom G9's lightweight portable design and high-speed performance.

Spinal Simplicity announces FDA 510(k) Clearance of its Sacroiliac Joint System, the Patriot-SI Posterior Implant, With a Unique Hybrid Indication for Use

Retrieved on: 
Wednesday, May 1, 2024
FDA, Sacrum, Food, Ilium, Arthralgia, Simplicity, Titanium, Patient, Physician, Synovial joint, Liberty, Sacroiliac joint, Patriot, Medical device

OVERLAND PARK, Kan., May 1, 2024 /PRNewswire-PRWeb/ -- Today, Spinal Simplicity is pleased to announce the Food and Drug Administration (FDA) 510(k) clearance of the Patriot-SI Posterior Implant System as part of a hybrid SI joint fusion construct to be used in conjunction with the Liberty-SI lateral transfixing system. The Patriot-SI Posterior Implant System is intended for sacroiliac joint fusion for conditions including sacroiliac disruptions and degenerative sacroiliitis. When the Patriot-SI System (i.e., an "in-line" or "intra-articular" device) is implanted, it must be used with a Spinal Simplicity Liberty-SI Lateral System device (i.e., a "transfixing" device) implanted across the same sacroiliac joint to create a hybrid SI joint fusion construct.

Key Points: 
  • Spinal Simplicity announced the FDA 510(k) clearance of its Patriot-SI Posterior Implant System, designed for sacroiliac joint fusion in combination with the Liberty-SI lateral system.
  • This clearance introduces a hybrid SI joint fusion construct, offering new treatment options for conditions such as sacroiliac disruptions and degenerative sacroiliitis.
  • The Patriot-SI Posterior Implant System is intended for sacroiliac joint fusion for conditions including sacroiliac disruptions and degenerative sacroiliitis.
  • "This announcement today marks a second product milestone in the past five months for Spinal Simplicity," said CEO Todd Moseley .

SAIL Fusion Announces FDA Clearance of its BowTie™ Sacroiliac Fusion System

Retrieved on: 
Tuesday, April 23, 2024
Biotechnology, Medical Supplies, Surgery, General Health, Health, FDA, Medical Devices, Hospitals, Pelvis, MIS, Rehabilitation, Surgeon, Sacroiliac joint dysfunction, TIE fighter, Orthopedic surgery, Arthrodesis, Patient, SAIL, CPT, Rigidity, Pleasure, Multimedia, 3D printing

SAIL Fusion, a medical device company focused on advancing the surgical treatment of sacroiliac joint dysfunction through solutions built upon proven AO principles, today announced that it has received FDA clearance for its novel BowTie Sacroiliac Fusion System.

Key Points: 
  • SAIL Fusion, a medical device company focused on advancing the surgical treatment of sacroiliac joint dysfunction through solutions built upon proven AO principles, today announced that it has received FDA clearance for its novel BowTie Sacroiliac Fusion System.
  • The system will be launched to a select group of initial surgeons in preparation for a greater expansion in the coming months.
  • “There hasn’t been meaningful differentiation in the SI fusion market for many years,” remarked David Jansen, the President & CEO of SAIL.
  • Our approach challenges the prevailing trend of lateral fixation that is more appropriate for stabilization rather than true joint fusion.

4WEB Medical Announces Regulatory Clearance of its Anterior Spine Truss System with Anchor Fixation

Retrieved on: 
Thursday, April 25, 2024
Spine, Growth, Medicine, Medical device

DALLAS, April 25, 2024 /PRNewswire/ -- 4WEB Medical, an orthopedic implant company focused on developing innovative implants that utilize its proprietary Truss Implant Technology™, announced that it received regulatory clearance to market the newest addition to the company's anterior lumbar implant portfolio, the Anterior Spine Truss System with Anchor Fixation (ASTS-AF).

Key Points: 
  • DALLAS, April 25, 2024 /PRNewswire/ -- 4WEB Medical, an orthopedic implant company focused on developing innovative implants that utilize its proprietary Truss Implant Technology™, announced that it received regulatory clearance to market the newest addition to the company's anterior lumbar implant portfolio, the Anterior Spine Truss System with Anchor Fixation (ASTS-AF).
  • 4WEB's current anterior lumbar implant offering includes a traditional interbody with the option of an integrated plate and a stand-alone interbody with screw fixation.
  • This regulatory clearance expands the portfolio with the ability to deliver anchor fixation through a less invasive surgical approach than traditional integrated spacers.
  • Geoff Bigos, Vice President of 4WEB Medical's Spine Division commented, "Adding anchor fixation to 4WEB's existing product offering will allow the company access to a new market segment, providing opportunity for growth."

Captiva Spine Shares the Publication of a Prospective Randomized Comparative Clinical Study of Accuracy and Safety Data

Retrieved on: 
Wednesday, April 24, 2024
Radiation, International Society, System, Hospital, Watchtower, Safety, National Yang-Ming University, Navigation, ASC, Surgeon, Doctor of Philosophy, Workflow, 3D, Anatomy, Environment, Acquisition, Comparison, Assistant, 2D, JNS, Annual general meeting, Taipei Veterans General Hospital, Journal, Medical imaging

JUPITER, Fla., April 24, 2024 /PRNewswire-PRWeb/ -- Captiva Spine®, a medical technology organization connecting healthcare professionals, distribution specialists, and healthcare facilities with cutting-edge spinal care technology, shares a recently published study in the Journal of Neurosurgery: Spine (JNS), affirming the effectiveness of the WatchTower Spine Navigation System and its novel 2D registration of a pre-operative CT for real-time 3D surgical navigation compared to navigation systems that utilize intra-operative CT scanners.

Key Points: 
  • The study concludes that the preoperative CT-based spinal navigation system matches the accuracy and safety of the conventional CT-based intra-operative system.
  • Real-time 3D surgical Navigation is emerging as the standard of care in spine surgery.
  • To date, navigation systems have relied on intra-operative CT scanning or touch registration of a pre-op CT scan to facilitate 3D navigation.
  • The study concludes that the preoperative CT-based spinal navigation system matches the accuracy and safety of the conventional CT-based intra-operative system.